On February 4, the European Union (EU)’s Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs added cannabidiol (CBD) “derived from extract or tincture or resin of cannabis” as a legal cosmetic ingredient to its CosIng guidelines. CosIng is a database of cosmetic regulations that expressly provides for authorized and unlawful ingredients and sets forth their
Our cannabis business attorneys have drafted many cannabis supply chain agreements (such as distribution agreements, licensing agreements, etc.) over the years. Generally, supply chain cannabis contracts follow the same format and the same nuanced provisions seem to pop up time and time again (I wrote about some of them previously in the context of tri-party
Five* Latin American nations are set to hold presidential elections in 2021, with some important legislative elections taking place as well. Some of these contests will have implications for cannabis policy, and we will be looking at what is at stake in each vote, starting with Ecuador, which heads to the polls next Sunday, February
The Oregon legislative session kicked off in earnest last week (online) with 28 proposed cannabis bills crowding the docket. We’ll probably see another dozen or so between now and June. In this post, I will run down the list and offer brief comments on each offering. Before diving in, though, some context will be useful.
Earlier this month, Circle K Stores Inc., owner and operator of the chain of Circle K convenience stores, filed a Trademark Trial and Appeal Board (“TTAB”) Notice of Opposition against Medical Marijuana, Inc., a California company with a pending U.S. federal trademark application for the following design mark (the “MM ‘K’ Mark”): The MM “K”
On Thursday, January 28, we will be hosting a FREE hour-long webinar discussing the business side of medical and recreational cannabis in Mexico. REGISTER TODAY! In our last post, we alerted you on the publication of the new Regulations on Sanitary Control for the Production, Research and Medical Use of Cannabis and Its Pharmacological Derivatives (the “Medical Regulations”). In
Last Friday, January 15th, the U.S. Department of Agriculture (the “USDA”) announced today’s publication of its hemp production final rule in the Federal Register, which will go into effect on March 22, 2021. This final rule builds on the interim final rule (the “IFR”) that was published on October 31, 2019. It includes revisions based
It has become an annual MLK Day tradition here at Canna Law Blog to remind our readers that, first and foremost, cannabis is a civil rights issue. We’ve explained why here, here, here and here. The past year ushered in some promising developments, from progress with the MORE Act, to state and local developments on social equity licensing measures, to increased
California has a rocky history when it comes to hemp-derived CBD. Despite the fact that the state adopted a robust medical and recreational cannabis program, for years it has taken the mystifying position that many kinds of hemp-derived products simply can’t be sold. Essentially, foods, beverages, and dietary supplements are a no-go according to the
MAG Hemp Regulations In October, Ecuador’s agriculture ministry (MAG) released hemp regulations, in the form of Acuerdo Ministerial No. 109 (English). This follows the National Assembly’s 2019 decriminalization of cannabis with a THC content of less than 1.0% THC (which entered into forced on June 21, 2020). The regulations distinguish between industrial hemp (cáñamo para
